News about Global Pharma

Aptar Pharma Gets NMPA Nod for Airless Drug Delivery System

Aptar Pharma has received approval by the National Medical Products Administration (NMPA) in China of Sinomune Pharmaceutical’s Li Fu metronidazole gel.

Global Pharma | 11/04/2024 | By Aishwarya |  977

Strides Pharma Receives FDA Approval for Antidepressant Drug

Strides Pharma Science’s subsidiary has gained approval from the US health regulator to market a generic antidepressant medication.

Global Pharma | 10/04/2024 | By Aishwarya |  1304

MOLLI Surgical Introduces OncoPen: A Revolutionary Tool in Breast Cancer Surgery

This sleek, pen-like wand seamlessly integrates with the acclaimed MOLLI® 2 System, providing sophisticated tools for precisely targeting and removing cancerous lesions.

Global Pharma | 10/04/2024 | By Abha |  726

Texas Cardiac Arrhythmia Institute Makes Medical Breakthrough with Novel Pulsed Field Ablation System

This heart arrhythmia, affecting millions worldwide, has seen a revolutionary approach after receiving approval from the US Food and Drug Administration.

Global Pharma | 10/04/2024 | By Abha |  486

Nvelop Therapeutics to Launch Dual Platforms for In Vivo Delivery of Next-Gen of Genetic Medicines

Nvelop Therapeutics has officially announced to develop the next generation of genetic medicines for a wide range of diseases.

Global Pharma | 10/04/2024 | By Aishwarya |  765

Invenra Signs Research Deal with Astellas Pharma to Boost Bispecific Therapeutic Research

Invenra Inc. has forged a strategic research agreement with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients.

Global Pharma | 10/04/2024 | By Aishwarya |  733

Bayer and Google Cloud to Accelerate Development of AI-Powered Healthcare Applications for Radiologists

As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud's technology, including its generative AI (gen AI) tools.

Global Pharma | 09/04/2024 | By Manvi |  669

FDA Grants Seven-Year Exclusivity to RADICAVA ORS for ALS Treatment

This recognition highlights the FDA's acknowledgment of the oral form of edaravone as a crucial advancement for ALS patients, providing a more accessible treatment option.

Global Pharma | 09/04/2024 | By Abha |  1550

Ayana Pharma Signs Five Year MSA with Scinai Bioservices for Drug Development

Scinai Immunotherapeutics Ltd. has announced that Ayana Pharma Ltd. signed a five-year Master Service Agreement (MSA) with the company's CDMO business unit, Scinai Bioservices.

Global Pharma | 09/04/2024 | By Aishwarya |  737

FDA Approves Onkos Surgical's Antibacterial Implants to Combat Orthopedic Contamination

A comprehensive body of preclinical safety and efficacy data substantiated the De Novo application.

Global Pharma | 09/04/2024 | By Abha |  204